Statistics for Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients.
Total visits
| views | |
|---|---|
| Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients. | 22 |
Total visits per month
| views | |
|---|---|
| marzo 2024 | 0 |
| abril 2024 | 1 |
| mayo 2024 | 3 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
File Visits
| views | |
|---|---|
| aff98de1-38b1-4538-aeef-8d6c6e684c66 | 2 |